{
    "clinical_study": {
        "@rank": "41731", 
        "acronym": "INHALATOR", 
        "arm_group": [
            {
                "arm_group_label": "Indacaterol", 
                "arm_group_type": "Experimental", 
                "description": "Indacaterol via Onbrize Breezhaler\u00ae device"
            }, 
            {
                "arm_group_label": "Tiotropium", 
                "arm_group_type": "Active Comparator", 
                "description": "Tiotropium via Spiriva Respimat\u00ae device"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will compare the correct use of, and patient preference for two drug delivery\n      systems (inhalers) in patients with COPD"
        }, 
        "brief_title": "Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease (COPD)", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male and female adults aged \u226540 years, who have signed an Informed Consent form prior\n             to initiation of any study-related procedure.\n\n          2. Co-operative outpatients with a diagnosis of moderate COPD as classified by the GOLD\n             Guidelines 2010 or grade A in GOLD 2011and including:\n\n               -  Smoking history of at least 10 pack years\n\n               -  FEV1/FVC < 70%\n\n        Exclusion criteria:\n\n          1. Previous diagnosis of asthma\n\n          2. Pregnant or nursing women\n\n          3. Hospitalization or emergency room attendance due to COPD exacerbation within 3\n             months prior to visit 1 Other protocol-defined   inclusion/exclusion criteria may\n             apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01727024", 
            "org_study_id": "CQAB149BBR02"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tiotropium", 
                "description": "Tiotropium via Spiriva Respimat\u00ae device once a day", 
                "intervention_name": "Tiotropium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Indacaterol", 
                "description": "Indacaterol via Onbrize Breezhaler\u00ae device once a day", 
                "intervention_name": "Indacaterol", 
                "intervention_type": "Drug", 
                "other_name": "Onbrez Breezhaler"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tiotropium"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breezhaler", 
            "Respimat", 
            "Indacaterol", 
            "Tiotropium"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Goiania", 
                        "country": "Brazil", 
                        "state": "GO", 
                        "zip": "74110-030"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belo Horizonte", 
                        "country": "Brazil", 
                        "state": "MG", 
                        "zip": "30130-100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belo Horizonte", 
                        "country": "Brazil", 
                        "state": "MG", 
                        "zip": "30150-281"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Suspended"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de Janeiro", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "20551-030"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90020-090"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90610-000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Florianopolis", 
                        "country": "Brazil", 
                        "state": "SC", 
                        "zip": "88040-970"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ribeirao Preto", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "14048-900"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "04039-004"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "01224-000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "04023-900"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }
        ], 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study to Evaluate the Preference, Satisfaction and Correct Use of Inhalers in Patients With Chronic Obstructive Pulmonary Disease", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "+41613241111"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The correct use of 2 drug delivery systems will be measured and compared to each other. Participants will be given written instructions prior to the first treatment at day one and a check list will be used to report the proper handling of the devices", 
            "measure": "Difference between 2 drug delivery systems with respect to their correct use at day 1", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01727024"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The correct use of 2 drug delivery systems will be measured and compared to each other after one week of participants handling the devices.", 
                "measure": "Difference between 2 drug delivery systems with respect to their correct use after one week of handling", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "Patient satisfaction with the inhalers' use will be measured using a questionaire.", 
                "measure": "Patient satisfaction with respect to the use of 2 drug delivery systems", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "Patient preference between the 2 inhalers will be measured using a questionaire.", 
                "measure": "Patient preference of  drug delivery system", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "Co-morbidities will be compared with difficulties of drug delivery system reported via a patient diary.", 
                "measure": "Comparison between comorbidities and difficulty with drug delivery system use", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}